eltrombopag olamine
Generic: ELTROMBOPAG OLAMINE·Brand: ELTROMBOPAG OLAMINE, PROMACTA, PROMACTA KIT
eltrombopag olamine: sourced relationships with 1 company · 2 FDA decisions.
eltrombopag olamine evidence translation
What we can confirm
2 FDA records
What it means
Source-backed records connect eltrombopag olamine to NVS; that link alone does not prove the drug works.
What to watch
Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected
Prepared research question
How could eltrombopag olamine → NVS affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
Dated Pipeline Records (2)
| Company | Dated record stage |
|---|---|
| Novartis AG (NVS) Reported 2008-11-20 · Current development: unknownSource | Approved |
| Novartis AG (NVS) Reported 2008-11-20 · Current development: unknownSource | Approved |
FDA Decisions2 records
Frequently asked questions
Which companies have sourced relationships with eltrombopag olamine?
eltrombopag olamine has dated SEC/FDA relationship records for Novartis AG.
What is eltrombopag olamine's latest FDA decision?
The most recent tracked FDA decision for eltrombopag olamine is Approval, dated August 24, 2015.